nodes	percent_of_prediction	percent_of_DWPC	metapath
Metoclopramide—CHRM1—epilepsy syndrome	0.29	0.728	CbGaD
Metoclopramide—CYP11B1—Phenytoin—epilepsy syndrome	0.212	0.933	CbGbCtD
Metoclopramide—CYP2D6—epilepsy syndrome	0.108	0.272	CbGaD
Metoclopramide—CYP2D6—Propofol—epilepsy syndrome	0.0153	0.0675	CbGbCtD
Metoclopramide—HTR3A—vagus nerve—epilepsy syndrome	0.00579	0.138	CbGeAlD
Metoclopramide—DRD3—telencephalic ventricle—epilepsy syndrome	0.00518	0.123	CbGeAlD
Metoclopramide—HTR4—telencephalon—epilepsy syndrome	0.00319	0.0758	CbGeAlD
Metoclopramide—HTR3A—ganglion—epilepsy syndrome	0.00223	0.053	CbGeAlD
Metoclopramide—DRD2—telencephalic ventricle—epilepsy syndrome	0.00219	0.0521	CbGeAlD
Metoclopramide—HTR4—brain—epilepsy syndrome	0.00144	0.0342	CbGeAlD
Metoclopramide—DRD2—ganglion—epilepsy syndrome	0.00136	0.0324	CbGeAlD
Metoclopramide—DRD2—hindbrain—epilepsy syndrome	0.00104	0.0246	CbGeAlD
Metoclopramide—HTR3A—brainstem—epilepsy syndrome	0.00097	0.023	CbGeAlD
Metoclopramide—HTR3A—forebrain—epilepsy syndrome	0.000936	0.0222	CbGeAlD
Metoclopramide—CYP17A1—medulla oblongata—epilepsy syndrome	0.000862	0.0205	CbGeAlD
Metoclopramide—HTR3A—telencephalon—epilepsy syndrome	0.000861	0.0205	CbGeAlD
Metoclopramide—DRD3—head—epilepsy syndrome	0.000775	0.0184	CbGeAlD
Metoclopramide—DRD3—nervous system—epilepsy syndrome	0.000735	0.0175	CbGeAlD
Metoclopramide—CHRM1—forebrain—epilepsy syndrome	0.000711	0.0169	CbGeAlD
Metoclopramide—DRD3—central nervous system—epilepsy syndrome	0.000707	0.0168	CbGeAlD
Metoclopramide—Sunitinib—ERN1—epilepsy syndrome	0.000692	0.0975	CrCbGaD
Metoclopramide—CYP17A1—head—epilepsy syndrome	0.000683	0.0162	CbGeAlD
Metoclopramide—CHRM1—telencephalon—epilepsy syndrome	0.000654	0.0155	CbGeAlD
Metoclopramide—CYP17A1—nervous system—epilepsy syndrome	0.000648	0.0154	CbGeAlD
Metoclopramide—CYP17A1—central nervous system—epilepsy syndrome	0.000623	0.0148	CbGeAlD
Metoclopramide—CYP2D6—hindbrain—epilepsy syndrome	0.000622	0.0148	CbGeAlD
Metoclopramide—DRD2—brainstem—epilepsy syndrome	0.000593	0.0141	CbGeAlD
Metoclopramide—DRD2—forebrain—epilepsy syndrome	0.000573	0.0136	CbGeAlD
Metoclopramide—DRD3—brain—epilepsy syndrome	0.000562	0.0133	CbGeAlD
Metoclopramide—HTR3A—head—epilepsy syndrome	0.000536	0.0127	CbGeAlD
Metoclopramide—DRD2—telencephalon—epilepsy syndrome	0.000526	0.0125	CbGeAlD
Metoclopramide—HTR3A—nervous system—epilepsy syndrome	0.000508	0.0121	CbGeAlD
Metoclopramide—Proparacaine—SCN3A—epilepsy syndrome	0.000496	0.0698	CrCbGaD
Metoclopramide—CYP17A1—brain—epilepsy syndrome	0.000495	0.0118	CbGeAlD
Metoclopramide—HTR3A—central nervous system—epilepsy syndrome	0.000489	0.0116	CbGeAlD
Metoclopramide—Oxybuprocaine—SCN3A—epilepsy syndrome	0.000453	0.0639	CrCbGaD
Metoclopramide—CHRM1—head—epilepsy syndrome	0.000407	0.00967	CbGeAlD
Metoclopramide—Procaine—CHRNA2—epilepsy syndrome	0.000402	0.0567	CrCbGaD
Metoclopramide—Sunitinib—TYRO3—epilepsy syndrome	0.000397	0.056	CrCbGaD
Metoclopramide—HTR3A—brain—epilepsy syndrome	0.000388	0.00923	CbGeAlD
Metoclopramide—CHRM1—nervous system—epilepsy syndrome	0.000386	0.00917	CbGeAlD
Metoclopramide—DRD2—midbrain—epilepsy syndrome	0.000378	0.00899	CbGeAlD
Metoclopramide—CHRM1—central nervous system—epilepsy syndrome	0.000372	0.00883	CbGeAlD
Metoclopramide—CYP2D6—brainstem—epilepsy syndrome	0.000356	0.00847	CbGeAlD
Metoclopramide—Proparacaine—SCN1A—epilepsy syndrome	0.000348	0.049	CrCbGaD
Metoclopramide—CYP2D6—forebrain—epilepsy syndrome	0.000344	0.00818	CbGeAlD
Metoclopramide—DRD2—head—epilepsy syndrome	0.000328	0.00779	CbGeAlD
Metoclopramide—Oxybuprocaine—SCN1A—epilepsy syndrome	0.000318	0.0448	CrCbGaD
Metoclopramide—CYP2D6—telencephalon—epilepsy syndrome	0.000316	0.00752	CbGeAlD
Metoclopramide—DRD2—nervous system—epilepsy syndrome	0.000311	0.00739	CbGeAlD
Metoclopramide—Proparacaine—SCN2A—epilepsy syndrome	0.000307	0.0432	CrCbGaD
Metoclopramide—Sunitinib—FYN—epilepsy syndrome	0.000301	0.0424	CrCbGaD
Metoclopramide—DRD2—central nervous system—epilepsy syndrome	0.000299	0.00711	CbGeAlD
Metoclopramide—CHRM1—brain—epilepsy syndrome	0.000295	0.00701	CbGeAlD
Metoclopramide—DRD2—cerebellum—epilepsy syndrome	0.000292	0.00695	CbGeAlD
Metoclopramide—Oxybuprocaine—SCN2A—epilepsy syndrome	0.000281	0.0395	CrCbGaD
Metoclopramide—Procainamide—SCN8A—epilepsy syndrome	0.000269	0.0379	CrCbGaD
Metoclopramide—Sunitinib—PTK2B—epilepsy syndrome	0.000256	0.0361	CrCbGaD
Metoclopramide—DRD2—brain—epilepsy syndrome	0.000238	0.00565	CbGeAlD
Metoclopramide—Sunitinib—RET—epilepsy syndrome	0.000218	0.0307	CrCbGaD
Metoclopramide—Procainamide—SCN9A—epilepsy syndrome	0.000218	0.0307	CrCbGaD
Metoclopramide—Amisulpride—HTR7—epilepsy syndrome	0.000213	0.03	CrCbGaD
Metoclopramide—Procainamide—SCN3A—epilepsy syndrome	0.000208	0.0293	CrCbGaD
Metoclopramide—Procainamide—SCN4A—epilepsy syndrome	0.0002	0.0282	CrCbGaD
Metoclopramide—CYP2D6—head—epilepsy syndrome	0.000197	0.00468	CbGeAlD
Metoclopramide—CYP2D6—nervous system—epilepsy syndrome	0.000187	0.00444	CbGeAlD
Metoclopramide—CYP2D6—central nervous system—epilepsy syndrome	0.00018	0.00427	CbGeAlD
Metoclopramide—CYP2D6—cerebellum—epilepsy syndrome	0.000176	0.00418	CbGeAlD
Metoclopramide—Procainamide—SCN1A—epilepsy syndrome	0.000146	0.0206	CrCbGaD
Metoclopramide—CYP2D6—brain—epilepsy syndrome	0.000143	0.00339	CbGeAlD
Metoclopramide—Oxybuprocaine—BCHE—epilepsy syndrome	0.000135	0.019	CrCbGaD
Metoclopramide—Procainamide—SCN2A—epilepsy syndrome	0.000129	0.0182	CrCbGaD
Metoclopramide—Chloroprocaine—BCHE—epilepsy syndrome	0.000126	0.0177	CrCbGaD
Metoclopramide—Cinchocaine—BCHE—epilepsy syndrome	0.00012	0.0169	CrCbGaD
Metoclopramide—Procaine—BCHE—epilepsy syndrome	0.00012	0.0169	CrCbGaD
Metoclopramide—Sunitinib—KDR—epilepsy syndrome	0.000114	0.0161	CrCbGaD
Metoclopramide—Amisulpride—HTR2A—epilepsy syndrome	0.000107	0.0151	CrCbGaD
Metoclopramide—Fatigue—Phenytoin—epilepsy syndrome	9.19e-05	0.000451	CcSEcCtD
Metoclopramide—Feeling abnormal—Zonisamide—epilepsy syndrome	9.18e-05	0.000451	CcSEcCtD
Metoclopramide—Fatigue—Oxcarbazepine—epilepsy syndrome	9.15e-05	0.000449	CcSEcCtD
Metoclopramide—Asthenia—Levetiracetam—epilepsy syndrome	9.11e-05	0.000447	CcSEcCtD
Metoclopramide—Hallucination—Gabapentin—epilepsy syndrome	9.08e-05	0.000446	CcSEcCtD
Metoclopramide—Dyspnoea—Carbamazepine—epilepsy syndrome	9.08e-05	0.000446	CcSEcCtD
Metoclopramide—Somnolence—Carbamazepine—epilepsy syndrome	9.05e-05	0.000444	CcSEcCtD
Metoclopramide—Urticaria—Felbamate—epilepsy syndrome	9.04e-05	0.000444	CcSEcCtD
Metoclopramide—Body temperature increased—Felbamate—epilepsy syndrome	9e-05	0.000442	CcSEcCtD
Metoclopramide—Diarrhoea—Propofol—epilepsy syndrome	8.99e-05	0.000441	CcSEcCtD
Metoclopramide—Tremor—Valproic Acid—epilepsy syndrome	8.97e-05	0.000441	CcSEcCtD
Metoclopramide—Neutropenia—Topiramate—epilepsy syndrome	8.97e-05	0.00044	CcSEcCtD
Metoclopramide—Insomnia—Lamotrigine—epilepsy syndrome	8.9e-05	0.000437	CcSEcCtD
Metoclopramide—Headache—Acetazolamide—epilepsy syndrome	8.86e-05	0.000435	CcSEcCtD
Metoclopramide—Pollakiuria—Topiramate—epilepsy syndrome	8.86e-05	0.000435	CcSEcCtD
Metoclopramide—Urticaria—Zonisamide—epilepsy syndrome	8.85e-05	0.000435	CcSEcCtD
Metoclopramide—Feeling abnormal—Clonazepam—epilepsy syndrome	8.85e-05	0.000434	CcSEcCtD
Metoclopramide—Erectile dysfunction—Topiramate—epilepsy syndrome	8.83e-05	0.000434	CcSEcCtD
Metoclopramide—Body temperature increased—Zonisamide—epilepsy syndrome	8.81e-05	0.000432	CcSEcCtD
Metoclopramide—Agitation—Valproic Acid—epilepsy syndrome	8.8e-05	0.000432	CcSEcCtD
Metoclopramide—Hypersensitivity—Vigabatrin—epilepsy syndrome	8.8e-05	0.000432	CcSEcCtD
Metoclopramide—Asthenia—Fosphenytoin—epilepsy syndrome	8.79e-05	0.000432	CcSEcCtD
Metoclopramide—Visual impairment—Gabapentin—epilepsy syndrome	8.79e-05	0.000432	CcSEcCtD
Metoclopramide—Feeling abnormal—Phenytoin—epilepsy syndrome	8.79e-05	0.000431	CcSEcCtD
Metoclopramide—Fatigue—Carbamazepine—epilepsy syndrome	8.78e-05	0.000431	CcSEcCtD
Metoclopramide—Dyspnoea—Lamotrigine—epilepsy syndrome	8.77e-05	0.000431	CcSEcCtD
Metoclopramide—Angioedema—Valproic Acid—epilepsy syndrome	8.75e-05	0.00043	CcSEcCtD
Metoclopramide—Somnolence—Lamotrigine—epilepsy syndrome	8.75e-05	0.000429	CcSEcCtD
Metoclopramide—Feeling abnormal—Oxcarbazepine—epilepsy syndrome	8.74e-05	0.000429	CcSEcCtD
Metoclopramide—Dizziness—Propofol—epilepsy syndrome	8.69e-05	0.000427	CcSEcCtD
Metoclopramide—Diarrhoea—Levetiracetam—epilepsy syndrome	8.69e-05	0.000427	CcSEcCtD
Metoclopramide—Hypersensitivity—Diazepam—epilepsy syndrome	8.66e-05	0.000425	CcSEcCtD
Metoclopramide—Leukopenia—Valproic Acid—epilepsy syndrome	8.57e-05	0.000421	CcSEcCtD
Metoclopramide—Asthenia—Vigabatrin—epilepsy syndrome	8.57e-05	0.000421	CcSEcCtD
Metoclopramide—Urticaria—Clonazepam—epilepsy syndrome	8.53e-05	0.000419	CcSEcCtD
Metoclopramide—Depression—Topiramate—epilepsy syndrome	8.52e-05	0.000419	CcSEcCtD
Metoclopramide—Dizziness—Midazolam—epilepsy syndrome	8.5e-05	0.000417	CcSEcCtD
Metoclopramide—Body temperature increased—Clonazepam—epilepsy syndrome	8.49e-05	0.000417	CcSEcCtD
Metoclopramide—Fatigue—Lamotrigine—epilepsy syndrome	8.48e-05	0.000416	CcSEcCtD
Metoclopramide—Urticaria—Phenytoin—epilepsy syndrome	8.47e-05	0.000416	CcSEcCtD
Metoclopramide—Palpitations—Valproic Acid—epilepsy syndrome	8.47e-05	0.000416	CcSEcCtD
Metoclopramide—Asthenia—Diazepam—epilepsy syndrome	8.44e-05	0.000414	CcSEcCtD
Metoclopramide—Body temperature increased—Phenytoin—epilepsy syndrome	8.43e-05	0.000414	CcSEcCtD
Metoclopramide—Urticaria—Oxcarbazepine—epilepsy syndrome	8.43e-05	0.000414	CcSEcCtD
Metoclopramide—Nervousness—Pregabalin—epilepsy syndrome	8.41e-05	0.000413	CcSEcCtD
Metoclopramide—Nausea—Acetazolamide—epilepsy syndrome	8.4e-05	0.000413	CcSEcCtD
Metoclopramide—Dizziness—Levetiracetam—epilepsy syndrome	8.4e-05	0.000412	CcSEcCtD
Metoclopramide—Feeling abnormal—Carbamazepine—epilepsy syndrome	8.39e-05	0.000412	CcSEcCtD
Metoclopramide—Body temperature increased—Oxcarbazepine—epilepsy syndrome	8.39e-05	0.000412	CcSEcCtD
Metoclopramide—Diarrhoea—Fosphenytoin—epilepsy syndrome	8.38e-05	0.000412	CcSEcCtD
Metoclopramide—Muscle spasms—Pregabalin—epilepsy syndrome	8.33e-05	0.000409	CcSEcCtD
Metoclopramide—Rash—Propofol—epilepsy syndrome	8.29e-05	0.000407	CcSEcCtD
Metoclopramide—Dermatitis—Propofol—epilepsy syndrome	8.28e-05	0.000406	CcSEcCtD
Metoclopramide—Hypertension—Valproic Acid—epilepsy syndrome	8.27e-05	0.000406	CcSEcCtD
Metoclopramide—Headache—Propofol—epilepsy syndrome	8.23e-05	0.000404	CcSEcCtD
Metoclopramide—Hypersensitivity—Zonisamide—epilepsy syndrome	8.21e-05	0.000403	CcSEcCtD
Metoclopramide—Diarrhoea—Vigabatrin—epilepsy syndrome	8.17e-05	0.000401	CcSEcCtD
Metoclopramide—Asthenia—Felbamate—epilepsy syndrome	8.17e-05	0.000401	CcSEcCtD
Metoclopramide—Anxiety—Valproic Acid—epilepsy syndrome	8.13e-05	0.000399	CcSEcCtD
Metoclopramide—Tremor—Pregabalin—epilepsy syndrome	8.11e-05	0.000398	CcSEcCtD
Metoclopramide—Feeling abnormal—Lamotrigine—epilepsy syndrome	8.11e-05	0.000398	CcSEcCtD
Metoclopramide—Rash—Midazolam—epilepsy syndrome	8.11e-05	0.000398	CcSEcCtD
Metoclopramide—Dizziness—Fosphenytoin—epilepsy syndrome	8.1e-05	0.000398	CcSEcCtD
Metoclopramide—Dermatitis—Midazolam—epilepsy syndrome	8.1e-05	0.000398	CcSEcCtD
Metoclopramide—Urticaria—Carbamazepine—epilepsy syndrome	8.09e-05	0.000397	CcSEcCtD
Metoclopramide—Headache—Midazolam—epilepsy syndrome	8.05e-05	0.000395	CcSEcCtD
Metoclopramide—Body temperature increased—Carbamazepine—epilepsy syndrome	8.05e-05	0.000395	CcSEcCtD
Metoclopramide—Diarrhoea—Diazepam—epilepsy syndrome	8.05e-05	0.000395	CcSEcCtD
Metoclopramide—Rash—Levetiracetam—epilepsy syndrome	8.01e-05	0.000393	CcSEcCtD
Metoclopramide—Dermatitis—Levetiracetam—epilepsy syndrome	8e-05	0.000393	CcSEcCtD
Metoclopramide—Asthenia—Zonisamide—epilepsy syndrome	7.99e-05	0.000392	CcSEcCtD
Metoclopramide—Agranulocytosis—Topiramate—epilepsy syndrome	7.98e-05	0.000392	CcSEcCtD
Metoclopramide—Agitation—Pregabalin—epilepsy syndrome	7.96e-05	0.000391	CcSEcCtD
Metoclopramide—Headache—Levetiracetam—epilepsy syndrome	7.95e-05	0.000391	CcSEcCtD
Metoclopramide—Angioedema—Pregabalin—epilepsy syndrome	7.91e-05	0.000389	CcSEcCtD
Metoclopramide—Hypersensitivity—Clonazepam—epilepsy syndrome	7.91e-05	0.000388	CcSEcCtD
Metoclopramide—Cisapride—CYP2C19—epilepsy syndrome	7.9e-05	0.0111	CrCbGaD
Metoclopramide—Dizziness—Vigabatrin—epilepsy syndrome	7.9e-05	0.000388	CcSEcCtD
Metoclopramide—Confusional state—Valproic Acid—epilepsy syndrome	7.88e-05	0.000387	CcSEcCtD
Metoclopramide—Hypersensitivity—Phenytoin—epilepsy syndrome	7.86e-05	0.000386	CcSEcCtD
Metoclopramide—Oedema—Valproic Acid—epilepsy syndrome	7.82e-05	0.000384	CcSEcCtD
Metoclopramide—Urticaria—Lamotrigine—epilepsy syndrome	7.82e-05	0.000384	CcSEcCtD
Metoclopramide—Hypersensitivity—Oxcarbazepine—epilepsy syndrome	7.82e-05	0.000384	CcSEcCtD
Metoclopramide—Bradycardia—Topiramate—epilepsy syndrome	7.81e-05	0.000384	CcSEcCtD
Metoclopramide—Nausea—Propofol—epilepsy syndrome	7.81e-05	0.000383	CcSEcCtD
Metoclopramide—Diarrhoea—Felbamate—epilepsy syndrome	7.79e-05	0.000382	CcSEcCtD
Metoclopramide—Body temperature increased—Lamotrigine—epilepsy syndrome	7.78e-05	0.000382	CcSEcCtD
Metoclopramide—Dizziness—Diazepam—epilepsy syndrome	7.78e-05	0.000382	CcSEcCtD
Metoclopramide—Leukopenia—Pregabalin—epilepsy syndrome	7.75e-05	0.000381	CcSEcCtD
Metoclopramide—Rash—Fosphenytoin—epilepsy syndrome	7.73e-05	0.000379	CcSEcCtD
Metoclopramide—Dermatitis—Fosphenytoin—epilepsy syndrome	7.72e-05	0.000379	CcSEcCtD
Metoclopramide—Nervousness—Gabapentin—epilepsy syndrome	7.71e-05	0.000379	CcSEcCtD
Metoclopramide—Asthenia—Clonazepam—epilepsy syndrome	7.7e-05	0.000378	CcSEcCtD
Metoclopramide—Headache—Fosphenytoin—epilepsy syndrome	7.68e-05	0.000377	CcSEcCtD
Metoclopramide—Palpitations—Pregabalin—epilepsy syndrome	7.65e-05	0.000376	CcSEcCtD
Metoclopramide—Asthenia—Phenytoin—epilepsy syndrome	7.65e-05	0.000376	CcSEcCtD
Metoclopramide—Nausea—Midazolam—epilepsy syndrome	7.64e-05	0.000375	CcSEcCtD
Metoclopramide—Hallucination—Topiramate—epilepsy syndrome	7.64e-05	0.000375	CcSEcCtD
Metoclopramide—Muscle spasms—Gabapentin—epilepsy syndrome	7.63e-05	0.000375	CcSEcCtD
Metoclopramide—Tachycardia—Valproic Acid—epilepsy syndrome	7.63e-05	0.000375	CcSEcCtD
Metoclopramide—Diarrhoea—Zonisamide—epilepsy syndrome	7.62e-05	0.000374	CcSEcCtD
Metoclopramide—Asthenia—Oxcarbazepine—epilepsy syndrome	7.61e-05	0.000374	CcSEcCtD
Metoclopramide—Nausea—Levetiracetam—epilepsy syndrome	7.54e-05	0.00037	CcSEcCtD
Metoclopramide—Rash—Vigabatrin—epilepsy syndrome	7.53e-05	0.00037	CcSEcCtD
Metoclopramide—Dizziness—Felbamate—epilepsy syndrome	7.53e-05	0.00037	CcSEcCtD
Metoclopramide—Dermatitis—Vigabatrin—epilepsy syndrome	7.52e-05	0.000369	CcSEcCtD
Metoclopramide—Convulsion—Pregabalin—epilepsy syndrome	7.5e-05	0.000368	CcSEcCtD
Metoclopramide—Hypersensitivity—Carbamazepine—epilepsy syndrome	7.5e-05	0.000368	CcSEcCtD
Metoclopramide—Headache—Vigabatrin—epilepsy syndrome	7.48e-05	0.000367	CcSEcCtD
Metoclopramide—Hypertension—Pregabalin—epilepsy syndrome	7.48e-05	0.000367	CcSEcCtD
Metoclopramide—Tremor—Gabapentin—epilepsy syndrome	7.44e-05	0.000365	CcSEcCtD
Metoclopramide—Procainamide—CHRM2—epilepsy syndrome	7.44e-05	0.0105	CrCbGaD
Metoclopramide—Rash—Diazepam—epilepsy syndrome	7.41e-05	0.000364	CcSEcCtD
Metoclopramide—Dermatitis—Diazepam—epilepsy syndrome	7.41e-05	0.000364	CcSEcCtD
Metoclopramide—Visual impairment—Topiramate—epilepsy syndrome	7.4e-05	0.000363	CcSEcCtD
Metoclopramide—Dizziness—Zonisamide—epilepsy syndrome	7.37e-05	0.000362	CcSEcCtD
Metoclopramide—Headache—Diazepam—epilepsy syndrome	7.37e-05	0.000362	CcSEcCtD
Metoclopramide—Anxiety—Pregabalin—epilepsy syndrome	7.35e-05	0.000361	CcSEcCtD
Metoclopramide—Diarrhoea—Clonazepam—epilepsy syndrome	7.35e-05	0.000361	CcSEcCtD
Metoclopramide—Hypotension—Valproic Acid—epilepsy syndrome	7.31e-05	0.000359	CcSEcCtD
Metoclopramide—Asthenia—Carbamazepine—epilepsy syndrome	7.3e-05	0.000359	CcSEcCtD
Metoclopramide—Agitation—Gabapentin—epilepsy syndrome	7.3e-05	0.000358	CcSEcCtD
Metoclopramide—Diarrhoea—Phenytoin—epilepsy syndrome	7.3e-05	0.000358	CcSEcCtD
Metoclopramide—Nausea—Fosphenytoin—epilepsy syndrome	7.28e-05	0.000357	CcSEcCtD
Metoclopramide—Diarrhoea—Oxcarbazepine—epilepsy syndrome	7.26e-05	0.000356	CcSEcCtD
Metoclopramide—Angioedema—Gabapentin—epilepsy syndrome	7.26e-05	0.000356	CcSEcCtD
Metoclopramide—Hypersensitivity—Lamotrigine—epilepsy syndrome	7.25e-05	0.000356	CcSEcCtD
Metoclopramide—Rash—Felbamate—epilepsy syndrome	7.18e-05	0.000352	CcSEcCtD
Metoclopramide—Dermatitis—Felbamate—epilepsy syndrome	7.17e-05	0.000352	CcSEcCtD
Metoclopramide—Headache—Felbamate—epilepsy syndrome	7.13e-05	0.00035	CcSEcCtD
Metoclopramide—Confusional state—Pregabalin—epilepsy syndrome	7.13e-05	0.00035	CcSEcCtD
Metoclopramide—Flushing—Topiramate—epilepsy syndrome	7.12e-05	0.00035	CcSEcCtD
Metoclopramide—Leukopenia—Gabapentin—epilepsy syndrome	7.11e-05	0.000349	CcSEcCtD
Metoclopramide—Dizziness—Clonazepam—epilepsy syndrome	7.1e-05	0.000349	CcSEcCtD
Metoclopramide—Nausea—Vigabatrin—epilepsy syndrome	7.09e-05	0.000348	CcSEcCtD
Metoclopramide—Insomnia—Valproic Acid—epilepsy syndrome	7.07e-05	0.000347	CcSEcCtD
Metoclopramide—Oedema—Pregabalin—epilepsy syndrome	7.07e-05	0.000347	CcSEcCtD
Metoclopramide—Asthenia—Lamotrigine—epilepsy syndrome	7.06e-05	0.000347	CcSEcCtD
Metoclopramide—Dizziness—Phenytoin—epilepsy syndrome	7.05e-05	0.000346	CcSEcCtD
Metoclopramide—Rash—Zonisamide—epilepsy syndrome	7.02e-05	0.000345	CcSEcCtD
Metoclopramide—Palpitations—Gabapentin—epilepsy syndrome	7.02e-05	0.000345	CcSEcCtD
Metoclopramide—Dermatitis—Zonisamide—epilepsy syndrome	7.02e-05	0.000345	CcSEcCtD
Metoclopramide—Dizziness—Oxcarbazepine—epilepsy syndrome	7.01e-05	0.000344	CcSEcCtD
Metoclopramide—Nausea—Diazepam—epilepsy syndrome	6.98e-05	0.000343	CcSEcCtD
Metoclopramide—Headache—Zonisamide—epilepsy syndrome	6.98e-05	0.000343	CcSEcCtD
Metoclopramide—Dyspnoea—Valproic Acid—epilepsy syndrome	6.97e-05	0.000342	CcSEcCtD
Metoclopramide—Diarrhoea—Carbamazepine—epilepsy syndrome	6.97e-05	0.000342	CcSEcCtD
Metoclopramide—Somnolence—Valproic Acid—epilepsy syndrome	6.95e-05	0.000341	CcSEcCtD
Metoclopramide—Tachycardia—Pregabalin—epilepsy syndrome	6.9e-05	0.000339	CcSEcCtD
Metoclopramide—Convulsion—Gabapentin—epilepsy syndrome	6.88e-05	0.000338	CcSEcCtD
Metoclopramide—Hypertension—Gabapentin—epilepsy syndrome	6.86e-05	0.000337	CcSEcCtD
Metoclopramide—Rash—Clonazepam—epilepsy syndrome	6.77e-05	0.000332	CcSEcCtD
Metoclopramide—Dermatitis—Clonazepam—epilepsy syndrome	6.76e-05	0.000332	CcSEcCtD
Metoclopramide—Sunitinib—ABCC2—epilepsy syndrome	6.76e-05	0.00953	CrCbGaD
Metoclopramide—Nausea—Felbamate—epilepsy syndrome	6.76e-05	0.000332	CcSEcCtD
Metoclopramide—Fatigue—Valproic Acid—epilepsy syndrome	6.74e-05	0.000331	CcSEcCtD
Metoclopramide—Anxiety—Gabapentin—epilepsy syndrome	6.74e-05	0.000331	CcSEcCtD
Metoclopramide—Dizziness—Carbamazepine—epilepsy syndrome	6.73e-05	0.000331	CcSEcCtD
Metoclopramide—Diarrhoea—Lamotrigine—epilepsy syndrome	6.73e-05	0.000331	CcSEcCtD
Metoclopramide—Headache—Clonazepam—epilepsy syndrome	6.73e-05	0.00033	CcSEcCtD
Metoclopramide—Rash—Phenytoin—epilepsy syndrome	6.72e-05	0.00033	CcSEcCtD
Metoclopramide—Dermatitis—Phenytoin—epilepsy syndrome	6.72e-05	0.00033	CcSEcCtD
Metoclopramide—Rash—Oxcarbazepine—epilepsy syndrome	6.69e-05	0.000328	CcSEcCtD
Metoclopramide—Dermatitis—Oxcarbazepine—epilepsy syndrome	6.68e-05	0.000328	CcSEcCtD
Metoclopramide—Headache—Phenytoin—epilepsy syndrome	6.68e-05	0.000328	CcSEcCtD
Metoclopramide—Headache—Oxcarbazepine—epilepsy syndrome	6.65e-05	0.000326	CcSEcCtD
Metoclopramide—Nausea—Zonisamide—epilepsy syndrome	6.62e-05	0.000325	CcSEcCtD
Metoclopramide—Hypotension—Pregabalin—epilepsy syndrome	6.6e-05	0.000324	CcSEcCtD
Metoclopramide—Confusional state—Gabapentin—epilepsy syndrome	6.53e-05	0.000321	CcSEcCtD
Metoclopramide—Dizziness—Lamotrigine—epilepsy syndrome	6.51e-05	0.000319	CcSEcCtD
Metoclopramide—Nervousness—Topiramate—epilepsy syndrome	6.49e-05	0.000319	CcSEcCtD
Metoclopramide—Oedema—Gabapentin—epilepsy syndrome	6.48e-05	0.000318	CcSEcCtD
Metoclopramide—Feeling abnormal—Valproic Acid—epilepsy syndrome	6.44e-05	0.000316	CcSEcCtD
Metoclopramide—Muscle spasms—Topiramate—epilepsy syndrome	6.42e-05	0.000315	CcSEcCtD
Metoclopramide—Rash—Carbamazepine—epilepsy syndrome	6.42e-05	0.000315	CcSEcCtD
Metoclopramide—Dermatitis—Carbamazepine—epilepsy syndrome	6.41e-05	0.000315	CcSEcCtD
Metoclopramide—Cisapride—HTR2A—epilepsy syndrome	6.41e-05	0.00903	CrCbGaD
Metoclopramide—Insomnia—Pregabalin—epilepsy syndrome	6.39e-05	0.000314	CcSEcCtD
Metoclopramide—Nausea—Clonazepam—epilepsy syndrome	6.38e-05	0.000313	CcSEcCtD
Metoclopramide—Headache—Carbamazepine—epilepsy syndrome	6.38e-05	0.000313	CcSEcCtD
Metoclopramide—Nausea—Phenytoin—epilepsy syndrome	6.33e-05	0.000311	CcSEcCtD
Metoclopramide—Tachycardia—Gabapentin—epilepsy syndrome	6.33e-05	0.000311	CcSEcCtD
Metoclopramide—Dyspnoea—Pregabalin—epilepsy syndrome	6.3e-05	0.000309	CcSEcCtD
Metoclopramide—Nausea—Oxcarbazepine—epilepsy syndrome	6.3e-05	0.000309	CcSEcCtD
Metoclopramide—Somnolence—Pregabalin—epilepsy syndrome	6.28e-05	0.000309	CcSEcCtD
Metoclopramide—Tremor—Topiramate—epilepsy syndrome	6.26e-05	0.000307	CcSEcCtD
Metoclopramide—Urticaria—Valproic Acid—epilepsy syndrome	6.21e-05	0.000305	CcSEcCtD
Metoclopramide—Rash—Lamotrigine—epilepsy syndrome	6.2e-05	0.000305	CcSEcCtD
Metoclopramide—Procainamide—BCHE—epilepsy syndrome	6.2e-05	0.00874	CrCbGaD
Metoclopramide—Dermatitis—Lamotrigine—epilepsy syndrome	6.2e-05	0.000304	CcSEcCtD
Metoclopramide—Body temperature increased—Valproic Acid—epilepsy syndrome	6.18e-05	0.000303	CcSEcCtD
Metoclopramide—Headache—Lamotrigine—epilepsy syndrome	6.16e-05	0.000303	CcSEcCtD
Metoclopramide—Agitation—Topiramate—epilepsy syndrome	6.14e-05	0.000301	CcSEcCtD
Metoclopramide—Fatigue—Pregabalin—epilepsy syndrome	6.09e-05	0.000299	CcSEcCtD
Metoclopramide—Hypotension—Gabapentin—epilepsy syndrome	6.06e-05	0.000297	CcSEcCtD
Metoclopramide—Nausea—Carbamazepine—epilepsy syndrome	6.05e-05	0.000297	CcSEcCtD
Metoclopramide—Leukopenia—Topiramate—epilepsy syndrome	5.98e-05	0.000294	CcSEcCtD
Metoclopramide—Sunitinib—ABCG2—epilepsy syndrome	5.98e-05	0.00842	CrCbGaD
Metoclopramide—Palpitations—Topiramate—epilepsy syndrome	5.9e-05	0.00029	CcSEcCtD
Metoclopramide—Insomnia—Gabapentin—epilepsy syndrome	5.86e-05	0.000288	CcSEcCtD
Metoclopramide—Cisapride—CYP2D6—epilepsy syndrome	5.86e-05	0.00826	CrCbGaD
Metoclopramide—Nausea—Lamotrigine—epilepsy syndrome	5.84e-05	0.000287	CcSEcCtD
Metoclopramide—Feeling abnormal—Pregabalin—epilepsy syndrome	5.82e-05	0.000286	CcSEcCtD
Metoclopramide—Convulsion—Topiramate—epilepsy syndrome	5.79e-05	0.000284	CcSEcCtD
Metoclopramide—Dyspnoea—Gabapentin—epilepsy syndrome	5.78e-05	0.000284	CcSEcCtD
Metoclopramide—Hypertension—Topiramate—epilepsy syndrome	5.77e-05	0.000283	CcSEcCtD
Metoclopramide—Somnolence—Gabapentin—epilepsy syndrome	5.76e-05	0.000283	CcSEcCtD
Metoclopramide—Hypersensitivity—Valproic Acid—epilepsy syndrome	5.76e-05	0.000283	CcSEcCtD
Metoclopramide—Anxiety—Topiramate—epilepsy syndrome	5.67e-05	0.000278	CcSEcCtD
Metoclopramide—Urticaria—Pregabalin—epilepsy syndrome	5.61e-05	0.000276	CcSEcCtD
Metoclopramide—Asthenia—Valproic Acid—epilepsy syndrome	5.61e-05	0.000275	CcSEcCtD
Metoclopramide—Fatigue—Gabapentin—epilepsy syndrome	5.59e-05	0.000274	CcSEcCtD
Metoclopramide—Body temperature increased—Pregabalin—epilepsy syndrome	5.59e-05	0.000274	CcSEcCtD
Metoclopramide—Confusional state—Topiramate—epilepsy syndrome	5.5e-05	0.00027	CcSEcCtD
Metoclopramide—Oedema—Topiramate—epilepsy syndrome	5.45e-05	0.000268	CcSEcCtD
Metoclopramide—Diarrhoea—Valproic Acid—epilepsy syndrome	5.35e-05	0.000263	CcSEcCtD
Metoclopramide—Feeling abnormal—Gabapentin—epilepsy syndrome	5.34e-05	0.000262	CcSEcCtD
Metoclopramide—Tachycardia—Topiramate—epilepsy syndrome	5.32e-05	0.000261	CcSEcCtD
Metoclopramide—Hypersensitivity—Pregabalin—epilepsy syndrome	5.21e-05	0.000256	CcSEcCtD
Metoclopramide—Dizziness—Valproic Acid—epilepsy syndrome	5.17e-05	0.000254	CcSEcCtD
Metoclopramide—Urticaria—Gabapentin—epilepsy syndrome	5.15e-05	0.000253	CcSEcCtD
Metoclopramide—Body temperature increased—Gabapentin—epilepsy syndrome	5.12e-05	0.000252	CcSEcCtD
Metoclopramide—Hypotension—Topiramate—epilepsy syndrome	5.1e-05	0.00025	CcSEcCtD
Metoclopramide—Asthenia—Pregabalin—epilepsy syndrome	5.07e-05	0.000249	CcSEcCtD
Metoclopramide—Insomnia—Topiramate—epilepsy syndrome	4.93e-05	0.000242	CcSEcCtD
Metoclopramide—Rash—Valproic Acid—epilepsy syndrome	4.93e-05	0.000242	CcSEcCtD
Metoclopramide—Dermatitis—Valproic Acid—epilepsy syndrome	4.92e-05	0.000242	CcSEcCtD
Metoclopramide—Headache—Valproic Acid—epilepsy syndrome	4.9e-05	0.00024	CcSEcCtD
Metoclopramide—Dyspnoea—Topiramate—epilepsy syndrome	4.86e-05	0.000239	CcSEcCtD
Metoclopramide—Somnolence—Topiramate—epilepsy syndrome	4.85e-05	0.000238	CcSEcCtD
Metoclopramide—Diarrhoea—Pregabalin—epilepsy syndrome	4.84e-05	0.000237	CcSEcCtD
Metoclopramide—Hypersensitivity—Gabapentin—epilepsy syndrome	4.77e-05	0.000234	CcSEcCtD
Metoclopramide—Fatigue—Topiramate—epilepsy syndrome	4.7e-05	0.000231	CcSEcCtD
Metoclopramide—Dizziness—Pregabalin—epilepsy syndrome	4.67e-05	0.000229	CcSEcCtD
Metoclopramide—Asthenia—Gabapentin—epilepsy syndrome	4.65e-05	0.000228	CcSEcCtD
Metoclopramide—Nausea—Valproic Acid—epilepsy syndrome	4.64e-05	0.000228	CcSEcCtD
Metoclopramide—Feeling abnormal—Topiramate—epilepsy syndrome	4.49e-05	0.000221	CcSEcCtD
Metoclopramide—Rash—Pregabalin—epilepsy syndrome	4.46e-05	0.000219	CcSEcCtD
Metoclopramide—Dermatitis—Pregabalin—epilepsy syndrome	4.45e-05	0.000219	CcSEcCtD
Metoclopramide—Diarrhoea—Gabapentin—epilepsy syndrome	4.43e-05	0.000218	CcSEcCtD
Metoclopramide—Headache—Pregabalin—epilepsy syndrome	4.43e-05	0.000217	CcSEcCtD
Metoclopramide—Urticaria—Topiramate—epilepsy syndrome	4.33e-05	0.000213	CcSEcCtD
Metoclopramide—Body temperature increased—Topiramate—epilepsy syndrome	4.31e-05	0.000212	CcSEcCtD
Metoclopramide—Dizziness—Gabapentin—epilepsy syndrome	4.29e-05	0.00021	CcSEcCtD
Metoclopramide—Nausea—Pregabalin—epilepsy syndrome	4.2e-05	0.000206	CcSEcCtD
Metoclopramide—Rash—Gabapentin—epilepsy syndrome	4.09e-05	0.000201	CcSEcCtD
Metoclopramide—Dermatitis—Gabapentin—epilepsy syndrome	4.08e-05	0.0002	CcSEcCtD
Metoclopramide—Headache—Gabapentin—epilepsy syndrome	4.06e-05	0.000199	CcSEcCtD
Metoclopramide—Hypersensitivity—Topiramate—epilepsy syndrome	4.02e-05	0.000197	CcSEcCtD
Metoclopramide—Asthenia—Topiramate—epilepsy syndrome	3.91e-05	0.000192	CcSEcCtD
Metoclopramide—Nausea—Gabapentin—epilepsy syndrome	3.85e-05	0.000189	CcSEcCtD
Metoclopramide—Diarrhoea—Topiramate—epilepsy syndrome	3.73e-05	0.000183	CcSEcCtD
Metoclopramide—Dizziness—Topiramate—epilepsy syndrome	3.61e-05	0.000177	CcSEcCtD
Metoclopramide—Rash—Topiramate—epilepsy syndrome	3.44e-05	0.000169	CcSEcCtD
Metoclopramide—Dermatitis—Topiramate—epilepsy syndrome	3.43e-05	0.000169	CcSEcCtD
Metoclopramide—Headache—Topiramate—epilepsy syndrome	3.42e-05	0.000168	CcSEcCtD
Metoclopramide—Procainamide—CYP2D6—epilepsy syndrome	3.4e-05	0.0048	CrCbGaD
Metoclopramide—Nausea—Topiramate—epilepsy syndrome	3.24e-05	0.000159	CcSEcCtD
Metoclopramide—Sunitinib—ABCB1—epilepsy syndrome	2.49e-05	0.00351	CrCbGaD
Metoclopramide—CHRM1—Signaling Pathways—CX3CR1—epilepsy syndrome	7.27e-06	6.01e-05	CbGpPWpGaD
Metoclopramide—HTR4—GPCR downstream signaling—AKT1—epilepsy syndrome	7.23e-06	5.98e-05	CbGpPWpGaD
Metoclopramide—DRD3—GPCR downstream signaling—PRKCB—epilepsy syndrome	7.23e-06	5.98e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—TSC1—epilepsy syndrome	7.21e-06	5.96e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—PTK2B—epilepsy syndrome	7.21e-06	5.96e-05	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—CASP3—epilepsy syndrome	7.17e-06	5.92e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—ALDH7A1—epilepsy syndrome	7.13e-06	5.89e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—CACNA1A—epilepsy syndrome	7.13e-06	5.89e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—CHRM2—epilepsy syndrome	7.13e-06	5.89e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—CX3CL1—epilepsy syndrome	7.13e-06	5.89e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—BDKRB1—epilepsy syndrome	7.13e-06	5.89e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—CDC42—epilepsy syndrome	7.12e-06	5.88e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—AGT—epilepsy syndrome	7.11e-06	5.87e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—GABBR1—epilepsy syndrome	7.09e-06	5.85e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—CCR2—epilepsy syndrome	7.02e-06	5.8e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—SST—epilepsy syndrome	7.02e-06	5.8e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—NTRK2—epilepsy syndrome	7.02e-06	5.8e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—ST3GAL3—epilepsy syndrome	6.98e-06	5.77e-05	CbGpPWpGaD
Metoclopramide—CYP17A1—Metabolism—POMC—epilepsy syndrome	6.98e-06	5.76e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—CDC42—epilepsy syndrome	6.96e-06	5.75e-05	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—JUN—epilepsy syndrome	6.96e-06	5.75e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—DUSP6—epilepsy syndrome	6.96e-06	5.75e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—GABBR1—epilepsy syndrome	6.94e-06	5.73e-05	CbGpPWpGaD
Metoclopramide—CYP11B2—Metabolism—PTGS2—epilepsy syndrome	6.9e-06	5.7e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—AVP—epilepsy syndrome	6.89e-06	5.69e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—ADRA2A—epilepsy syndrome	6.87e-06	5.67e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—PLAT—epilepsy syndrome	6.84e-06	5.65e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—ADSL—epilepsy syndrome	6.84e-06	5.65e-05	CbGpPWpGaD
Metoclopramide—CYP11B1—Metabolism—ALB—epilepsy syndrome	6.8e-06	5.62e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—HRH3—epilepsy syndrome	6.79e-06	5.61e-05	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—MMP9—epilepsy syndrome	6.77e-06	5.6e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—AVP—epilepsy syndrome	6.74e-06	5.57e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—GLUL—epilepsy syndrome	6.71e-06	5.54e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—OPRM1—epilepsy syndrome	6.69e-06	5.53e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—HRH3—epilepsy syndrome	6.65e-06	5.49e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—BDKRB2—epilepsy syndrome	6.6e-06	5.45e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—CXCL12—epilepsy syndrome	6.6e-06	5.45e-05	CbGpPWpGaD
Metoclopramide—DRD3—GPCR downstream signaling—POMC—epilepsy syndrome	6.59e-06	5.44e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—CACNA1D—epilepsy syndrome	6.58e-06	5.44e-05	CbGpPWpGaD
Metoclopramide—HTR4—Signaling by GPCR—AKT1—epilepsy syndrome	6.57e-06	5.43e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—PRKCB—epilepsy syndrome	6.57e-06	5.43e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—OPRM1—epilepsy syndrome	6.55e-06	5.41e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—IL6ST—epilepsy syndrome	6.54e-06	5.41e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—JUNB—epilepsy syndrome	6.48e-06	5.35e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—CNR1—epilepsy syndrome	6.48e-06	5.35e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—PLCB1—epilepsy syndrome	6.45e-06	5.33e-05	CbGpPWpGaD
Metoclopramide—DRD2—GPCR downstream signaling—CCR5—epilepsy syndrome	6.45e-06	5.33e-05	CbGpPWpGaD
Metoclopramide—CYP17A1—Metabolism—ALB—epilepsy syndrome	6.36e-06	5.26e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—HTR7—epilepsy syndrome	6.32e-06	5.22e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—CCR3—epilepsy syndrome	6.32e-06	5.22e-05	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—CCR5—epilepsy syndrome	6.31e-06	5.22e-05	CbGpPWpGaD
Metoclopramide—DRD2—GPCR downstream signaling—HTR2A—epilepsy syndrome	6.31e-06	5.22e-05	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—SRC—epilepsy syndrome	6.24e-06	5.16e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—CCR3—epilepsy syndrome	6.18e-06	5.11e-05	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—HTR2A—epilepsy syndrome	6.18e-06	5.1e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—TXNRD1—epilepsy syndrome	6.16e-06	5.09e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—NPY—epilepsy syndrome	6.15e-06	5.09e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—ATP2A2—epilepsy syndrome	6.15e-06	5.09e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—HBEGF—epilepsy syndrome	6.13e-06	5.07e-05	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—VEGFA—epilepsy syndrome	6.08e-06	5.02e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—NPY—epilepsy syndrome	6.02e-06	4.98e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—ATP2A2—epilepsy syndrome	6.02e-06	4.98e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—AKT3—epilepsy syndrome	6.02e-06	4.97e-05	CbGpPWpGaD
Metoclopramide—DRD2—GPCR downstream signaling—AGT—epilepsy syndrome	5.99e-06	4.95e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—POMC—epilepsy syndrome	5.98e-06	4.94e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—AQP1—epilepsy syndrome	5.98e-06	4.94e-05	CbGpPWpGaD
Metoclopramide—CYP11B1—Metabolism—PTGS2—epilepsy syndrome	5.95e-06	4.92e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—CXCL2—epilepsy syndrome	5.94e-06	4.91e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—OXT—epilepsy syndrome	5.94e-06	4.91e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—CRH—epilepsy syndrome	5.94e-06	4.91e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—HSPB1—epilepsy syndrome	5.94e-06	4.91e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—CCL3—epilepsy syndrome	5.94e-06	4.91e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—ADAM10—epilepsy syndrome	5.88e-06	4.86e-05	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—AGT—epilepsy syndrome	5.86e-06	4.84e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—CCR5—epilepsy syndrome	5.86e-06	4.84e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—CCL2—epilepsy syndrome	5.85e-06	4.84e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—HSPB1—epilepsy syndrome	5.81e-06	4.8e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—OXT—epilepsy syndrome	5.81e-06	4.8e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—CXCL2—epilepsy syndrome	5.81e-06	4.8e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—CRH—epilepsy syndrome	5.81e-06	4.8e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—CCL3—epilepsy syndrome	5.81e-06	4.8e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—CCR5—epilepsy syndrome	5.73e-06	4.74e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—HTR2A—epilepsy syndrome	5.73e-06	4.74e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—HTR2A—epilepsy syndrome	5.61e-06	4.64e-05	CbGpPWpGaD
Metoclopramide—CYP17A1—Metabolism—PTGS2—epilepsy syndrome	5.56e-06	4.6e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—S100B—epilepsy syndrome	5.56e-06	4.6e-05	CbGpPWpGaD
Metoclopramide—DRD2—GPCR downstream signaling—PRKCB—epilepsy syndrome	5.53e-06	4.57e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—TSC1—epilepsy syndrome	5.52e-06	4.56e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—PTK2B—epilepsy syndrome	5.52e-06	4.56e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—SOCS3—epilepsy syndrome	5.51e-06	4.55e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—CDC42—epilepsy syndrome	5.49e-06	4.54e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—AGT—epilepsy syndrome	5.44e-06	4.49e-05	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—PRKCB—epilepsy syndrome	5.42e-06	4.48e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—KCNJ11—epilepsy syndrome	5.4e-06	4.47e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—CHRM3—epilepsy syndrome	5.4e-06	4.47e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—TSC1—epilepsy syndrome	5.4e-06	4.46e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—PTK2B—epilepsy syndrome	5.4e-06	4.46e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—CCR2—epilepsy syndrome	5.37e-06	4.44e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—SST—epilepsy syndrome	5.37e-06	4.44e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—NTRK2—epilepsy syndrome	5.37e-06	4.44e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—AGT—epilepsy syndrome	5.32e-06	4.4e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—DUSP6—epilepsy syndrome	5.32e-06	4.4e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—AVP—epilepsy syndrome	5.32e-06	4.39e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—SST—epilepsy syndrome	5.26e-06	4.34e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—CCR2—epilepsy syndrome	5.26e-06	4.34e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—NTRK2—epilepsy syndrome	5.26e-06	4.34e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—ADRA2A—epilepsy syndrome	5.26e-06	4.34e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—PLAT—epilepsy syndrome	5.23e-06	4.32e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—DUSP6—epilepsy syndrome	5.21e-06	4.3e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—ADRA2A—epilepsy syndrome	5.14e-06	4.25e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—PLAT—epilepsy syndrome	5.12e-06	4.23e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—CXCL12—epilepsy syndrome	5.05e-06	4.17e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—BDKRB2—epilepsy syndrome	5.05e-06	4.17e-05	CbGpPWpGaD
Metoclopramide—DRD2—GPCR downstream signaling—POMC—epilepsy syndrome	5.04e-06	4.17e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—HES1—epilepsy syndrome	5.03e-06	4.16e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—PRKCB—epilepsy syndrome	5.03e-06	4.15e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—IL6ST—epilepsy syndrome	5.01e-06	4.14e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—CNR1—epilepsy syndrome	4.96e-06	4.09e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—JUNB—epilepsy syndrome	4.96e-06	4.09e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—CXCL12—epilepsy syndrome	4.94e-06	4.08e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—BDKRB2—epilepsy syndrome	4.94e-06	4.08e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—PLCB1—epilepsy syndrome	4.94e-06	4.08e-05	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—POMC—epilepsy syndrome	4.93e-06	4.08e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—PRKCB—epilepsy syndrome	4.92e-06	4.06e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—IL6ST—epilepsy syndrome	4.9e-06	4.05e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—FYN—epilepsy syndrome	4.89e-06	4.04e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—H2AFX—epilepsy syndrome	4.87e-06	4.03e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—MEF2C—epilepsy syndrome	4.86e-06	4.02e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—JUNB—epilepsy syndrome	4.85e-06	4.01e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—CNR1—epilepsy syndrome	4.85e-06	4.01e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—HTR7—epilepsy syndrome	4.84e-06	4e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—PLCB1—epilepsy syndrome	4.83e-06	3.99e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—HTR7—epilepsy syndrome	4.73e-06	3.91e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—YWHAZ—epilepsy syndrome	4.7e-06	3.88e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—HBEGF—epilepsy syndrome	4.69e-06	3.88e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—NGF—epilepsy syndrome	4.65e-06	3.84e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—AKT3—epilepsy syndrome	4.61e-06	3.81e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—HBEGF—epilepsy syndrome	4.59e-06	3.8e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—POMC—epilepsy syndrome	4.58e-06	3.78e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—CCR5—epilepsy syndrome	4.52e-06	3.74e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—AKT3—epilepsy syndrome	4.51e-06	3.73e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—ADAM10—epilepsy syndrome	4.5e-06	3.72e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—POMC—epilepsy syndrome	4.48e-06	3.7e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—CCL2—epilepsy syndrome	4.48e-06	3.7e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—HTR2A—epilepsy syndrome	4.43e-06	3.66e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—ABCG2—epilepsy syndrome	4.41e-06	3.64e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—ADAM10—epilepsy syndrome	4.4e-06	3.64e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—CCL2—epilepsy syndrome	4.38e-06	3.62e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—CYP2C19—epilepsy syndrome	4.29e-06	3.55e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—CYP11A1—epilepsy syndrome	4.27e-06	3.53e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—S100B—epilepsy syndrome	4.26e-06	3.52e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—SOCS3—epilepsy syndrome	4.21e-06	3.48e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—TSC2—epilepsy syndrome	4.2e-06	3.47e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—CDC42—epilepsy syndrome	4.2e-06	3.47e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—AGT—epilepsy syndrome	4.2e-06	3.47e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—S100B—epilepsy syndrome	4.16e-06	3.44e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—SOCS3—epilepsy syndrome	4.12e-06	3.41e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—APOE—epilepsy syndrome	4.11e-06	3.4e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—CDC42—epilepsy syndrome	4.11e-06	3.4e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—AVP—epilepsy syndrome	4.07e-06	3.36e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—KDR—epilepsy syndrome	4.03e-06	3.33e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—AVP—epilepsy syndrome	3.98e-06	3.29e-05	CbGpPWpGaD
Metoclopramide—HTR4—Signaling Pathways—AKT1—epilepsy syndrome	3.88e-06	3.21e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—PRKCB—epilepsy syndrome	3.88e-06	3.21e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—IL6ST—epilepsy syndrome	3.86e-06	3.19e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—HES1—epilepsy syndrome	3.85e-06	3.18e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—HES1—epilepsy syndrome	3.77e-06	3.11e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—FYN—epilepsy syndrome	3.74e-06	3.09e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—H2AFX—epilepsy syndrome	3.73e-06	3.08e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—MEF2C—epilepsy syndrome	3.72e-06	3.08e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—ADRA2A—epilepsy syndrome	3.67e-06	3.03e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—FYN—epilepsy syndrome	3.66e-06	3.03e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—BCHE—epilepsy syndrome	3.65e-06	3.02e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—H2AFX—epilepsy syndrome	3.65e-06	3.02e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—MEF2C—epilepsy syndrome	3.64e-06	3.01e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—YWHAZ—epilepsy syndrome	3.6e-06	2.97e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—NGF—epilepsy syndrome	3.56e-06	2.94e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—POMC—epilepsy syndrome	3.53e-06	2.92e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—YWHAZ—epilepsy syndrome	3.52e-06	2.91e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—SLC2A1—epilepsy syndrome	3.48e-06	2.88e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—NGF—epilepsy syndrome	3.48e-06	2.88e-05	CbGpPWpGaD
Metoclopramide—CYP11B2—Metabolism—AKT1—epilepsy syndrome	3.47e-06	2.87e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—CCR5—epilepsy syndrome	3.46e-06	2.86e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—CCL2—epilepsy syndrome	3.46e-06	2.86e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—PLCB1—epilepsy syndrome	3.44e-06	2.85e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—TH—epilepsy syndrome	3.43e-06	2.84e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—CCR5—epilepsy syndrome	3.39e-06	2.8e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—HTR2A—epilepsy syndrome	3.39e-06	2.8e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—HTR2A—epilepsy syndrome	3.31e-06	2.74e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—TSC2—epilepsy syndrome	3.22e-06	2.66e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—AGT—epilepsy syndrome	3.21e-06	2.65e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—TSC2—epilepsy syndrome	3.15e-06	2.6e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—APOE—epilepsy syndrome	3.15e-06	2.6e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—AGT—epilepsy syndrome	3.14e-06	2.6e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—FGF2—epilepsy syndrome	3.13e-06	2.58e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—KDR—epilepsy syndrome	3.08e-06	2.55e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—APOE—epilepsy syndrome	3.08e-06	2.55e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—KDR—epilepsy syndrome	3.02e-06	2.49e-05	CbGpPWpGaD
Metoclopramide—CYP11B1—Metabolism—AKT1—epilepsy syndrome	2.99e-06	2.47e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—PRKCB—epilepsy syndrome	2.97e-06	2.45e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—IL6ST—epilepsy syndrome	2.96e-06	2.44e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—PRKCB—epilepsy syndrome	2.91e-06	2.4e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—RELA—epilepsy syndrome	2.9e-06	2.4e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—IL6ST—epilepsy syndrome	2.89e-06	2.39e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—HMOX1—epilepsy syndrome	2.86e-06	2.37e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—MTOR—epilepsy syndrome	2.85e-06	2.35e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—CAT—epilepsy syndrome	2.83e-06	2.34e-05	CbGpPWpGaD
Metoclopramide—CYP17A1—Metabolism—AKT1—epilepsy syndrome	2.8e-06	2.31e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—ABCB1—epilepsy syndrome	2.75e-06	2.27e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—POMC—epilepsy syndrome	2.7e-06	2.23e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—POMC—epilepsy syndrome	2.65e-06	2.19e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—CCL2—epilepsy syndrome	2.65e-06	2.19e-05	CbGpPWpGaD
Metoclopramide—DRD3—GPCR downstream signaling—AKT1—epilepsy syndrome	2.64e-06	2.18e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—CASP3—epilepsy syndrome	2.62e-06	2.16e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—CCL2—epilepsy syndrome	2.59e-06	2.14e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—GPX1—epilepsy syndrome	2.56e-06	2.11e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—JUN—epilepsy syndrome	2.54e-06	2.1e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—MMP9—epilepsy syndrome	2.47e-06	2.04e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling by GPCR—AKT1—epilepsy syndrome	2.4e-06	1.98e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—FGF2—epilepsy syndrome	2.39e-06	1.98e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—FGF2—epilepsy syndrome	2.34e-06	1.93e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—SRC—epilepsy syndrome	2.28e-06	1.88e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—AGT—epilepsy syndrome	2.24e-06	1.85e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—VEGFA—epilepsy syndrome	2.22e-06	1.83e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—RELA—epilepsy syndrome	2.22e-06	1.83e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—APOE—epilepsy syndrome	2.2e-06	1.81e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—MTOR—epilepsy syndrome	2.18e-06	1.8e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—RELA—epilepsy syndrome	2.17e-06	1.8e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—MTOR—epilepsy syndrome	2.13e-06	1.76e-05	CbGpPWpGaD
Metoclopramide—DRD2—GPCR downstream signaling—AKT1—epilepsy syndrome	2.02e-06	1.67e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—CASP3—epilepsy syndrome	2e-06	1.65e-05	CbGpPWpGaD
Metoclopramide—CHRM1—GPCR downstream signaling—AKT1—epilepsy syndrome	1.98e-06	1.63e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—CASP3—epilepsy syndrome	1.96e-06	1.62e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—JUN—epilepsy syndrome	1.95e-06	1.61e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—JUN—epilepsy syndrome	1.9e-06	1.57e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—MMP9—epilepsy syndrome	1.89e-06	1.56e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—POMC—epilepsy syndrome	1.89e-06	1.56e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—MMP9—epilepsy syndrome	1.85e-06	1.53e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling by GPCR—AKT1—epilepsy syndrome	1.84e-06	1.52e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling by GPCR—AKT1—epilepsy syndrome	1.8e-06	1.48e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—SRC—epilepsy syndrome	1.74e-06	1.44e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—ALB—epilepsy syndrome	1.72e-06	1.42e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—SRC—epilepsy syndrome	1.71e-06	1.41e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—VEGFA—epilepsy syndrome	1.7e-06	1.4e-05	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—VEGFA—epilepsy syndrome	1.66e-06	1.37e-05	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—PTGS2—epilepsy syndrome	1.5e-06	1.24e-05	CbGpPWpGaD
Metoclopramide—DRD3—Signaling Pathways—AKT1—epilepsy syndrome	1.42e-06	1.17e-05	CbGpPWpGaD
Metoclopramide—DRD2—Signaling Pathways—AKT1—epilepsy syndrome	1.08e-06	8.96e-06	CbGpPWpGaD
Metoclopramide—CHRM1—Signaling Pathways—AKT1—epilepsy syndrome	1.06e-06	8.77e-06	CbGpPWpGaD
Metoclopramide—CYP2D6—Metabolism—AKT1—epilepsy syndrome	7.56e-07	6.25e-06	CbGpPWpGaD
